Costs, Effectiveness, Benefits, and Economics Multipaper
Understanding the Texas HPV Vaccination Program: A Data-Driven Evaluation of Health Outcomes and Cost-Effectiveness
Friday, November 14, 2025
9:00 AM - 9:15 AM CST
The University of Texas MD Anderson Cancer Center created and served as the backbone organization for the HPV Vaccination Implementation Community (HPV VIC). Within the HPV VIC, our evaluation partners, RTI International, conducted a CEA on 10 organizations implementing 12 evidence-based HPV vaccination projects across 18 Texas counties. The initiative was designed to accelerate implementation and create a collaborative environment to strengthen vaccination uptake. The HPV VIC fostered resource sharing and sustainable systems change among Texas communities that has reduced barriers to vaccination. This panel discussion will include two presentations from subject matter experts from MD Anderson and RTI International to discuss the HPV VI evaluation framework to assess the dynamic multi-level collaborative and highlight one aspect of the evaluation on cost effectiveness.
Charles Amos; Olga Khavjou; Stephanie Nutt; Katy Oestman; Ruth Rechis; Aileen Rivell; Zohra Tayebali; Katherine Treiman